9-ING-41 in Patients With Advanced Cancers
Actuate Therapeutics Inc.
Actuate Therapeutics Inc.
OHSU Knight Cancer Institute
Atreca, Inc.
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Imunon
Guangxi Medical University
Western Regional Medical Center
University of Iowa
Santa Maria Biotherapeutics
Washington University School of Medicine